Townsquare Capital LLC Buys 651 Shares of Agilent Technologies, Inc. (NYSE:A)

Townsquare Capital LLC lifted its stake in Agilent Technologies, Inc. (NYSE:A) by 33.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,593 shares of the medical research company’s stock after purchasing an additional 651 shares during the quarter. Townsquare Capital LLC’s holdings in Agilent Technologies were worth $348,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently bought and sold shares of the company. Flynn Zito Capital Management LLC lifted its holdings in shares of Agilent Technologies by 3.8% during the fourth quarter. Flynn Zito Capital Management LLC now owns 1,871 shares of the medical research company’s stock valued at $251,000 after purchasing an additional 69 shares in the last quarter. IFP Advisors Inc grew its stake in shares of Agilent Technologies by 17.7% in the fourth quarter. IFP Advisors Inc now owns 458 shares of the medical research company’s stock worth $62,000 after acquiring an additional 69 shares during the period. Tiemann Investment Advisors LLC raised its holdings in shares of Agilent Technologies by 5.6% during the fourth quarter. Tiemann Investment Advisors LLC now owns 1,423 shares of the medical research company’s stock valued at $191,000 after purchasing an additional 75 shares during the last quarter. Rothschild Investment LLC boosted its holdings in Agilent Technologies by 19.2% in the fourth quarter. Rothschild Investment LLC now owns 491 shares of the medical research company’s stock worth $66,000 after purchasing an additional 79 shares during the last quarter. Finally, CIBC Private Wealth Group LLC raised its stake in Agilent Technologies by 1.2% during the 4th quarter. CIBC Private Wealth Group LLC now owns 7,479 shares of the medical research company’s stock valued at $1,025,000 after buying an additional 87 shares during the last quarter.

Analysts Set New Price Targets

A number of research firms recently commented on A. TD Cowen upped their price objective on Agilent Technologies to $135.00 and gave the company a “buy” rating in a research report on Thursday, April 10th. Jefferies Financial Group dropped their price objective on shares of Agilent Technologies from $135.00 to $116.00 and set a “hold” rating on the stock in a report on Monday. Barclays reduced their target price on shares of Agilent Technologies from $138.00 to $115.00 and set an “equal weight” rating for the company in a report on Thursday, April 10th. Robert W. Baird reduced their price objective on Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating for the company in a research note on Thursday, February 27th. Finally, StockNews.com raised Agilent Technologies from a “hold” rating to a “buy” rating in a report on Tuesday, December 24th. Seven analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $143.00.

Insider Activity at Agilent Technologies

In other news, Director Daniel K. Podolsky sold 1,819 shares of the firm’s stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $116.46, for a total value of $211,840.74. Following the transaction, the director now owns 35,737 shares in the company, valued at $4,161,931.02. This trade represents a 4.84 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, VP Rodney Gonsalves sold 1,908 shares of the business’s stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $121.98, for a total value of $232,737.84. Following the sale, the vice president now owns 21,786 shares of the company’s stock, valued at $2,657,456.28. The trade was a 8.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here.

Agilent Technologies Stock Down 2.1 %

A opened at $100.29 on Tuesday. The company has a quick ratio of 1.66, a current ratio of 2.20 and a debt-to-equity ratio of 0.56. The company has a market capitalization of $28.59 billion, a PE ratio of 23.06, a price-to-earnings-growth ratio of 2.89 and a beta of 1.19. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $155.35. The firm has a 50-day simple moving average of $118.79 and a two-hundred day simple moving average of $132.00.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, beating analysts’ consensus estimates of $1.27 by $0.04. The firm had revenue of $1.68 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. Analysts forecast that Agilent Technologies, Inc. will post 5.54 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be issued a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a yield of 0.99%. The ex-dividend date of this dividend is Tuesday, April 1st. Agilent Technologies’s dividend payout ratio (DPR) is 22.76%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.